Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation

Published:2020-05-07 Issue:6 Volume:99 Page:1377-1387
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Pasic Ivan,Lipton Jeffrey H.,Kim Dennis D.,Viswabandya Auro,Kumar Rajat,Lam Wilson,Law Arjun D.,Mattsson Jonas,Michelis Fotios V.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-020-04033-2.pdf

Reference74 articles.

1. Lee SJ (2016) Classification systems for chronic graft-versus-host disease. Blood 129:30–37. https://doi.org/10.1182/blood-2016-07-686642

2. Zeiser R, Blazar BR (2017) Acute graft-versus-host disease - biologic process, prevention, and therapy. New Engl J Med 377:2167–2179. https://doi.org/10.1056/nejmra1609337

3. Jagasia MH, Greinix HT, Arora M et al (2014) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biology Blood Marrow Transplant J Am Soc Blood Marrow Transplant 21:389–401.e1. https://doi.org/10.1016/j.bbmt.2014.12.001

4. MacDonald KP, Betts BC, Couriel D (2018) Emerging therapeutics for the control of chronic graft-versus-host disease. Biol Blood Marrow Tr 24:19–26. https://doi.org/10.1016/j.bbmt.2017.10.006

5. Sarantopoulos S, Cardones AR, Llivan K (2019) How I treat refractory chronic graft-versus-host disease. Blood 133:1191–1200. https://doi.org/10.1182/blood-2018-04-785899

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical peripheral blood stem cell transplantation improves the survival of older patients with myeloid malignancies under low-dose antithymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis;2024-08-13

2. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

3. Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia;Leukemia & Lymphoma;2024-07-07

4. Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients;Annals of Hematology;2024-05-29

5. Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-05